1. Arora P, Boyne D, Slater JJ, Gupta A, Brenner DR, Druzdzel MJ. Bayesian networks for risk prediction using real-world data: a tool for precision medicine. Value Health 2019;22:439-445.
3. Reed M, Huang J, Brand R, Graetz I, Neugebauer R, Fireman B, Jaffe M, Ballard DW, Hsu J. Implementation of an outpatient electronic health record and emergency department visits, hospitalizations, and office visits among patients with diabetes. JAMA 2013;310:1060-1065.
4. Shnorhavorian M, Bittner R, Wright JL, Schwartz SM. Maternal risk factors for congenital urinary anomalies: results of a population-based case-control study. Urology 2011;78:1156-1161.
5. Yuasa T, Urakami S, Yamamoto S, Yonese J, Nakano K, Kodaira M, Takahashi S, Hatake K, Inamura K, Ishikwa Y, Fukui I. Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancer. Urology 2011;77:831-835.
6. Park SB, Hwang KT, Chung CK, Roy D, Yoo C. Causal Bayesian gene networks associated with bone, brain and lung metastasis of breast cancer. Clin Exp Metastasis 2020;37:657-674.
8. Pearl J. Probabilistic reasoning in intelligent systems: networks of plausible inference. San Francisco: Morgan Kaufmann Publishers; 1988.
9. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res 2013;41:D991-D995.
10. Zhang K, Zhang M, Zhu J, Hong W. Screening of gene mutations associated with bone metastasis in nonsmall cell lung cancer. J Cancer Res Ther 2016;12((Supple):C186-C190.
11. Dat le T, Matsuo T, Yoshimaru T, Kakiuchi S, Goto H, Hanibuchi M, Kuramoto T, Nishioka Y, Sone S, Katagiri T. Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice. Int J Oncol 2012;40:1455-1469.
12. Huang Y, Chu T, Liao T, Hu X, Huang B. Downregulation of lysosomal and further gene expression characterization in lung cancer patients with bone metastasis. Artif Cells Nanomed Biotechnol 2017;45:758-764.
13. Lipton A, Theriault RL, Hortobagyi GN, Simeone J, Knight RD, Mellars K, Reitsma DJ, Heffernan M, Seaman JJ. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer 2000;88:1082-1090.